{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:40:12Z","timestamp":1792600812884,"version":"4.5.0"},"reference-count":45,"publisher":"MyJove Corporation","issue":"213","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoVE"],"DOI":"10.3791\/67189","type":"journal-article","created":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T19:00:16Z","timestamp":1732906816000},"source":"Crossref","is-referenced-by-count":1,"title":["Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model"],"prefix":"10.3791","author":[{"given":"Yanjiani","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaoyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangyang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2098","published-online":{"date-parts":[[2024,11,29]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"15019","DOI":"10.1038\/nrdp.2015.19","type":"journal-article","article-title":"Type 2 diabetes mellitus","volume":"1","author":"Defronzo","year":"2015","unstructured":"Defronzo, R. A. et al. Type 2 diabetes mellitus. Nat Rev Dis Primers. 1, 15019 (2015).","journal-title":"Nat Rev Dis Primers"},{"issue":"6","key":"ref2","doi-asserted-by":"crossref","DOI":"10.1007\/s11886-019-1133-9","type":"journal-article","article-title":"Mortality and cardiovascular disease in type 1 and type 2 diabetes","volume":"21","author":"Htay","year":"2019","unstructured":"Htay, T. et al. Mortality and cardiovascular disease in type 1 and type 2 diabetes. Curr Cardiol Rep. 21 (6), 45 (2019).","journal-title":"Curr Cardiol Rep"},{"issue":"4","key":"ref3","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCRESAHA.117.311586","type":"journal-article","article-title":"Diabetic cardiomyopathy: An update of mechanisms contributing to this clinical entity","volume":"122","author":"Jia","year":"2018","unstructured":"Jia, G., Hill, M. A., Sowers, J. R. Diabetic cardiomyopathy: An update of mechanisms contributing to this clinical entity. Circ Res. 122 (4), 624-638 (2018).","journal-title":"Circ Res"},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1161\/CIRCRESAHA.118.311371","type":"journal-article","article-title":"Heart failure in type 2 diabetes mellitus","volume":"124","author":"Kenny","year":"2019","unstructured":"Kenny, H. C., Abel, E. D. Heart failure in type 2 diabetes mellitus. Circ Res. 124 (1), 121-141 (2019).","journal-title":"Circ Res"},{"issue":"4","key":"ref5","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1161\/CIRCHEARTFAILURE.114.001963","type":"journal-article","article-title":"Smad3 signaling promotes fibrosis while preserving cardiac and aortic geometry in obese diabetic mice","volume":"8","author":"Biernacka","year":"2015","unstructured":"Biernacka, A. et al. Smad3 signaling promotes fibrosis while preserving cardiac and aortic geometry in obese diabetic mice. Circ Heart Fail. 8 (4), 788-798 (2015).","journal-title":"Circ Heart Fail"},{"issue":"4","key":"ref6","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00395-008-0715-2","type":"journal-article","article-title":"Reduced MMP-2 activity contributes to cardiac fibrosis in experimental diabetic cardiomyopathy","volume":"103","author":"Van Linthout","year":"2008","unstructured":"Van Linthout, S. et al. Reduced MMP-2 activity contributes to cardiac fibrosis in experimental diabetic cardiomyopathy. Basic Res Cardiol. 103 (4), 319-327 (2008).","journal-title":"Basic Res Cardiol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.freeradbiomed.2015.11.013","type":"journal-article","article-title":"Therapeutic inhibition of mitochondrial reactive oxygen species with mito-tempo reduces diabetic cardiomyopathy","volume":"90","author":"Ni","year":"2016","unstructured":"Ni, R. et al. Therapeutic inhibition of mitochondrial reactive oxygen species with mito-tempo reduces diabetic cardiomyopathy. Free Radic Biol Med. 90, 12-23 (2016).","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"ref8","doi-asserted-by":"crossref","first-page":"625","DOI":"10.2337\/db10-1164","type":"journal-article","article-title":"Diabetic downregulation of Nrf2 activity via erk contributes to oxidative stress-induced insulin resistance in cardiac cells in vitro and in vivo","volume":"60","author":"Tan","year":"2011","unstructured":"Tan, Y. et al. Diabetic downregulation of Nrf2 activity via erk contributes to oxidative stress-induced insulin resistance in cardiac cells in vitro and in vivo. Diabetes. 60 (2), 625-633 (2011).","journal-title":"Diabetes"},{"issue":"48","key":"ref9","doi-asserted-by":"crossref","first-page":"4243","DOI":"10.1093\/eurheartj\/ehy596","type":"journal-article","article-title":"Heart failure and diabetes: Metabolic alterations and therapeutic interventions: A state-of-the-art review from the translational research committee of the heart failure association-european society of cardiology","volume":"39","author":"Maack","year":"2018","unstructured":"Maack, C. et al. Heart failure and diabetes: Metabolic alterations and therapeutic interventions: A state-of-the-art review from the translational research committee of the heart failure association-european society of cardiology. Eur Heart J. 39 (48), 4243-4254 (2018).","journal-title":"Eur Heart J"},{"issue":"3","key":"ref10","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00125-021-05637-7","type":"journal-article","article-title":"structural and biochemical changes in diabetes and the development of heart failure","volume":"65","author":"Ho","year":"2022","unstructured":"Ho, K. L. et al. Metabolic, structural and biochemical changes in diabetes and the development of heart failure. Diabetologia. 65 (3), 411-423 (2022).","journal-title":"Diabetologia"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4239\/wjd.v6.i1.109","type":"journal-article","article-title":"Beta-cell dysfunction: Its critical role in prevention and management of type 2 diabetes","volume":"6","author":"Saisho","year":"2015","unstructured":"Saisho, Y. Beta-cell dysfunction: Its critical role in prevention and management of type 2 diabetes. World J Diabetes. 6 (1), 109-124 (2015).","journal-title":"World J Diabetes"},{"issue":"17","key":"ref12","doi-asserted-by":"crossref","first-page":"6275","DOI":"10.3390\/ijms21176275","type":"journal-article","article-title":"Pathophysiology of type 2 diabetes mellitus","volume":"21","author":"Galicia-Garcia","year":"2020","unstructured":"Galicia-Garcia, U. et al. Pathophysiology of type 2 diabetes mellitus. Int J Mol Sci. 21 (17), 6275 (2020).","journal-title":"Int J Mol Sci"},{"issue":"1","key":"ref13","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3181\/00379727-126-32401","type":"journal-article","article-title":"Studies of the diabetogenic action of streptozotocin","volume":"126","author":"Junod","year":"1967","unstructured":"Junod, A. et al. Studies of the diabetogenic action of streptozotocin. Proc Soc Exp Biol Med. 126 (1), 201-205 (1967).","journal-title":"Proc Soc Exp Biol Med"},{"issue":"131","key":"ref14","first-page":"e56672","type":"journal-article","article-title":"Study of in vivo glucose metabolism in high-fat diet-fed mice using oral glucose tolerance test (OGTT) and insulin tolerance test (ITT)","author":"Einwallner","year":"2018","unstructured":"Einwallner, E. Nagy, C. Study of in vivo glucose metabolism in high-fat diet-fed mice using oral glucose tolerance test (OGTT) and insulin tolerance test (ITT). J Vis Exp. 131, e56672 (2018).","journal-title":"J Vis Exp"},{"issue":"147","key":"ref15","first-page":"e59431","type":"journal-article","article-title":"Induction of right ventricular failure by pulmonary artery constriction and evaluation of right ventricular function in mice","author":"Wang","year":"2019","unstructured":"Wang, Q. et al. Induction of right ventricular failure by pulmonary artery constriction and evaluation of right ventricular function in mice. J Vis Exp. 147, e59431 (2019).","journal-title":"J Vis Exp"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/cvr\/cvaa110","type":"journal-article","article-title":"Towards standardization of echocardiography for the evaluation of left ventricular function in adult rodents: A position paper of the ESC working group on myocardial function","volume":"117","author":"Zacchigna","year":"2021","unstructured":"Zacchigna, S. et al. Towards standardization of echocardiography for the evaluation of left ventricular function in adult rodents: A position paper of the ESC working group on myocardial function. Cardiovasc Res. 117 (1), 43-59 (2021).","journal-title":"Cardiovasc Res"},{"key":"ref17","volume-title":"Paraffin sides experiment report","year":"2022","unstructured":"Servicebio. Paraffin sides experiment report. At <https:\/\/www.servicebio.com\/data-detail?id=5556&code=BLZPSYBG> (2022)."},{"key":"ref18","volume-title":"staining experiment report","year":"2022","unstructured":"Servicebio. Masson staining experiment report. At <https:\/\/www.servicebio.com\/data-detail?id=5588&code=RSSYBG> (2022)."},{"key":"ref19","volume-title":"Paraffin WGA staining protocol","year":"2022","unstructured":"Servicebio. Paraffin WGA staining protocol. At <https:\/\/www.servicebio.com\/data-detail?id=5041&code=MYYGSYBG> (2022)."},{"issue":"2","key":"ref20","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.diabres.2013.11.002","type":"journal-article","article-title":"Global estimates of diabetes prevalence for 2013 and projections for 2035","volume":"103","author":"Guariguata","year":"2014","unstructured":"Guariguata, L. et al. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract. 103 (2), 137-149 (2014).","journal-title":"Diabetes Res Clin Pract"},{"issue":"9","key":"ref21","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41569-020-0339-2","type":"journal-article","article-title":"Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: Preclinical and clinical evidence","volume":"17","author":"Tan","year":"2020","unstructured":"Tan, Y. et al. Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: Preclinical and clinical evidence. Nat Rev Cardiol. 17 (9), 585-607 (2020).","journal-title":"Nat Rev Cardiol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"109037","DOI":"10.1016\/j.jnutbio.2022.109037","type":"journal-article","article-title":"A comprehensive review on high -fat diet-induced diabetes mellitus: An epigenetic view","volume":"107","author":"Prasad","year":"2022","unstructured":"Prasad, M. et al. A comprehensive review on high -fat diet-induced diabetes mellitus: An epigenetic view. J Nutr Biochem. 107, 109037 (2022).","journal-title":"J Nutr Biochem"},{"issue":"6505","key":"ref23","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/372425a0","type":"journal-article","article-title":"Positional cloning of the mouse obese gene and its human homologue","volume":"372","author":"Zhang","year":"1994","unstructured":"Zhang, Y. et al. Positional cloning of the mouse obese gene and its human homologue. Nature. 372 (6505), 425-432 (1994).","journal-title":"Nature"},{"issue":"1","key":"ref24","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12933-019-0820-6","type":"journal-article","article-title":"Sglt2 inhibition with empagliflozin improves coronary microvascular function and cardiac contractility in prediabetic ob\/ob(-\/-) mice","volume":"18","author":"Adingupu","year":"2019","unstructured":"Adingupu, D. D. et al. Sglt2 inhibition with empagliflozin improves coronary microvascular function and cardiac contractility in prediabetic ob\/ob(-\/-) mice. Cardiovasc Diabetol. 18 (1), 16 (2019).","journal-title":"Cardiovasc Diabetol"},{"issue":"5","key":"ref25","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1007\/s00125-012-2495-3","type":"journal-article","article-title":"Coenzyme q10 attenuates diastolic dysfunction, cardiomyocyte hypertrophy and cardiac fibrosis in the db\/db mouse model of type 2 diabetes","volume":"55","author":"Huynh","year":"2012","unstructured":"Huynh, K. et al. Coenzyme q10 attenuates diastolic dysfunction, cardiomyocyte hypertrophy and cardiac fibrosis in the db\/db mouse model of type 2 diabetes. Diabetologia. 55 (5), 1544-1553 (2012).","journal-title":"Diabetologia"},{"issue":"8","key":"ref26","doi-asserted-by":"crossref","first-page":"165807","DOI":"10.1016\/j.bbadis.2020.165807","type":"journal-article","article-title":"Empagliflozin improves left ventricular diastolic function of db\/db mice","volume":"1866","author":"Moellmann","year":"2020","unstructured":"Moellmann, J. et al. Empagliflozin improves left ventricular diastolic function of db\/db mice. Biochim Biophys Acta Mol Basis Dis. 1866 (8), 165807 (2020).","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/1475-2840-12-172","type":"journal-article","article-title":"Eplerenone attenuated cardiac steatosis, apoptosis and diastolic dysfunction in experimental type-ii diabetes","volume":"12","author":"Ramirez","year":"2013","unstructured":"Ramirez, E. et al. Eplerenone attenuated cardiac steatosis, apoptosis and diastolic dysfunction in experimental type-ii diabetes. Cardiovasc Diabetol. 12, 172 (2013).","journal-title":"Cardiovasc Diabetol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"656795","DOI":"10.1155\/2015\/656795","type":"journal-article","article-title":"Updating experimental models of diabetic cardiomyopathy","volume":"2015","author":"Fuentes-Antras","year":"2015","unstructured":"Fuentes-Antras, J. et al. Updating experimental models of diabetic cardiomyopathy. J Diabetes Res. 2015, 656795 (2015).","journal-title":"J Diabetes Res"},{"issue":"1","key":"ref29","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s00395-018-0711-0","type":"journal-article","article-title":"Of mice and men: Models and mechanisms of diabetic cardiomyopathy","volume":"114","author":"Riehle","year":"2018","unstructured":"Riehle, C. Bauersachs, J. Of mice and men: Models and mechanisms of diabetic cardiomyopathy. Basic Res Cardiol. 114 (1), 2 (2018).","journal-title":"Basic Res Cardiol"},{"issue":"1","key":"ref30","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1161\/CIRCRESAHA.120.314458","type":"journal-article","article-title":"Adiponectin, leptin and cardiovascular disorders","volume":"128","author":"Zhao","year":"2021","unstructured":"Zhao, S., Kusminski, C. M., Scherer, P. E. Adiponectin, leptin and cardiovascular disorders. Circ Res. 128 (1), 136-149 (2021).","journal-title":"Circ Res"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"6106051","DOI":"10.1155\/2018\/6106051","type":"journal-article","article-title":"A mouse model of beta-cell dysfunction as seen in human type 2 diabetes","volume":"2018","author":"Parilla","year":"2018","unstructured":"Parilla, J. H., Willard, J. R., Barrow, B. M., Zraika, S. A mouse model of beta-cell dysfunction as seen in human type 2 diabetes. J Diabetes Res. 2018, 6106051 (2018).","journal-title":"J Diabetes Res"},{"issue":"2","key":"ref32","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2174\/1573399810666140508121012","type":"journal-article","article-title":"Leptin- and leptin receptor-deficient rodent models: Relevance for human type 2 diabetes","volume":"10","author":"Wang","year":"2014","unstructured":"Wang, B., Chandrasekera, P. C., Pippin, J. J. Leptin- and leptin receptor-deficient rodent models: Relevance for human type 2 diabetes. Curr Diabetes Rev. 10 (2), 131-145 (2014).","journal-title":"Curr Diabetes Rev"},{"issue":"4","key":"ref33","doi-asserted-by":"crossref","first-page":"C772","DOI":"10.1152\/ajpcell.00086.2005","type":"journal-article","article-title":"Alterations in cardiac contractile performance and sarcoplasmic reticulum function in sucrose-fed rats is associated with insulin resistance","volume":"291","author":"Vasanji","year":"2006","unstructured":"Vasanji, Z., Cantor, E. J., Juric, D., Moyen, M., Netticadan, T. Alterations in cardiac contractile performance and sarcoplasmic reticulum function in sucrose-fed rats is associated with insulin resistance. Am J Physiol Cell Physiol. 291 (4), C772-C780 (2006).","journal-title":"Am J Physiol Cell Physiol"},{"issue":"2","key":"ref34","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1093\/cvr\/cvp017","type":"journal-article","article-title":"Mechanisms for increased myocardial fatty acid utilization following short-term high-fat feeding","volume":"82","author":"Wright","year":"2009","unstructured":"Wright, J. J. et al. Mechanisms for increased myocardial fatty acid utilization following short-term high-fat feeding. Cardiovasc Res. 82 (2), 351-360 (2009).","journal-title":"Cardiovasc Res"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jnutbio.2018.09.007","type":"journal-article","article-title":"Long-term exposure to high-sucrose diet down-regulates hepatic endoplasmic reticulum-stress adaptive pathways and potentiates de novo lipogenesis in weaned male mice","volume":"62","author":"Flister","year":"2018","unstructured":"Flister, K. F. T. et al. Long-term exposure to high-sucrose diet down-regulates hepatic endoplasmic reticulum-stress adaptive pathways and potentiates de novo lipogenesis in weaned male mice. J Nutr Biochem. 62, 155-166 (2018).","journal-title":"J Nutr Biochem"},{"issue":"10","key":"ref36","doi-asserted-by":"crossref","first-page":"10872","DOI":"10.1096\/fj.201900767R","type":"journal-article","article-title":"The nuclear and mitochondrial sirtuins, sirt6 and sirt3, regulate each other's activity and protect the heart from developing obesity-mediated diabetic cardiomyopathy","volume":"33","author":"Kanwal","year":"2019","unstructured":"Kanwal, A., Pillai, V. B., Samant, S., Gupta, M., Gupta, M. P. The nuclear and mitochondrial sirtuins, sirt6 and sirt3, regulate each other's activity and protect the heart from developing obesity-mediated diabetic cardiomyopathy. FASEB J. 33 (10), 10872-10888 (2019).","journal-title":"FASEB J"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"S215","DOI":"10.2337\/diabetes.53.suppl_3.S215","type":"journal-article","article-title":"The high-fat diet-fed mouse: A model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes","volume":"53 Suppl 3","author":"Winzell","year":"2004","unstructured":"Winzell, M. S. Ahren, B. The high-fat diet-fed mouse: A model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes. Diabetes. 53 Suppl 3, S215-S219 (2004).","journal-title":"Diabetes"},{"issue":"10","key":"ref38","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/j.1463-1326.2012.01619.x","type":"journal-article","article-title":"Effects of saxagliptin and sitagliptin on glycaemic control and pancreatic beta-cell mass in a streptozotocin-induced mouse model of type 2 diabetes","volume":"14","author":"Poucher","year":"2012","unstructured":"Poucher, S. M. et al. Effects of saxagliptin and sitagliptin on glycaemic control and pancreatic beta-cell mass in a streptozotocin-induced mouse model of type 2 diabetes. Diabetes Obes Metab. 14 (10), 918-926 (2012).","journal-title":"Diabetes Obes Metab"},{"issue":"4","key":"ref39","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1358\/mf.2009.31.4.1373958","type":"journal-article","article-title":"Experimental rodent models of type 2 diabetes: A review","volume":"31","author":"Islam","year":"2009","unstructured":"Islam, M. S. Loots Du, T. Experimental rodent models of type 2 diabetes: A review. Methods Find Exp Clin Pharmacol. 31 (4), 249-261 (2009).","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"2902351","DOI":"10.1155\/2016\/2902351","type":"journal-article","article-title":"An overview of murine high fat diet as a model for type 2 diabetes mellitus","volume":"2016","author":"Heydemann","year":"2016","unstructured":"Heydemann, A. An overview of murine high fat diet as a model for type 2 diabetes mellitus. J Diabetes Res. 2016, 2902351 (2016).","journal-title":"J Diabetes Res"},{"issue":"9","key":"ref41","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.2337\/diab.37.9.1163","type":"journal-article","article-title":"Diet-induced type ii diabetes in c57bl\/6j mice","volume":"37","author":"Surwit","year":"1988","unstructured":"Surwit, R. S., Kuhn, C. M., Cochrane, C., Mccubbin, J. A., Feinglos, M. N. Diet-induced type ii diabetes in c57bl\/6j mice. Diabetes. 37 (9), 1163-1167 (1988).","journal-title":"Diabetes"},{"issue":"1","key":"ref42","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1210\/er.2006-0035","type":"journal-article","article-title":"The genetic landscape of type 2 diabetes in mice","volume":"28","author":"Clee","year":"2007","unstructured":"Clee, S. M. Attie, A. D. The genetic landscape of type 2 diabetes in mice. Endocr Rev. 28 (1), 48-83 (2007).","journal-title":"Endocr Rev"},{"issue":"11","key":"ref43","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1016\/0006-2952(93)90657-I","type":"journal-article","article-title":"Degradation products of streptozotocin do not induce hyperglycemia in rats","volume":"46","author":"Lee","year":"1993","unstructured":"Lee, J. Y., Kim, M. J., Moon, C. K., Chung, J. H. Degradation products of streptozotocin do not induce hyperglycemia in rats. Biochem Pharmacol. 46 (11), 2111-2113 (1993).","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"ref44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4239\/wjd.v12.i1.1","type":"journal-article","article-title":"Diabetes-induced changes in cardiac voltage-gated ion channels","volume":"12","author":"Ozturk","year":"2021","unstructured":"Ozturk, N., Uslu, S., Ozdemir, S. Diabetes-induced changes in cardiac voltage-gated ion channels. World J Diabetes. 12 (1), 1-18 (2021).","journal-title":"World J Diabetes"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3389\/fphys.2019.00135","type":"journal-article","article-title":"The association between diabetes mellitus and atrial fibrillation: Clinical and mechanistic insights","volume":"10","author":"Bohne","year":"2019","unstructured":"Bohne, L. J., Johnson, D., Rose, R. A., Wilton, S. B., Gillis, A. M. The association between diabetes mellitus and atrial fibrillation: Clinical and mechanistic insights. Front Physiol. 10, 135 (2019).","journal-title":"Front Physiol"}],"container-title":["Journal of Visualized Experiments"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/app.jove.com\/t\/67189\/modeling-and-evaluation-of-murine-diabetic-cardiomyopathy-model","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:51:33Z","timestamp":1792597893000},"score":1,"resource":{"primary":{"URL":"https:\/\/app.jove.com\/t\/67189\/modeling-and-evaluation-of-murine-diabetic-cardiomyopathy-model"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,29]]},"references-count":45,"journal-issue":{"issue":"213","published-online":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.3791\/67189","relation":{},"ISSN":["1940-087X"],"issn-type":[{"value":"1940-087X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,29]]}}}